Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Closed
Phase 2
This trial is looking at adding a drug called hydroxychloroquine to treatment for chronic myeloid leukaemia that has already responded well to imatinib.
Recruitment start: 1 April 2010
Recruitment end: 14 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tessa Holyoake
Cancer Research UK Clinical Trials Unit
Glasgow
Experimental Cancer Medicine Centre (ECMC)
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer
Last reviewed: 14 Jan 2015
CRUK internal database number: 4541
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
